Ulf Richenberg

Former Secretary & General Counsel at Karolinska Development AB

Ulf Richenberg

Ulf Richenberg

Former Secretary & General Counsel at Karolinska Development AB

Overview
Career Highlights

Karolinska Development AB
AB Stokab
Scribona AB

RelSci Relationships

60

Number of Boards

4

Birthday

1955

Age

65

Contact Data
Trying to get in touch with Ulf Richenberg? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Ulf Richenberg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Business Officer at Asarina Pharma AB

Relationship likelihood: Strong

Former Chief Financial Officer at Karolinska Development AB (Private Equity)

Relationship likelihood: Strong

Lead Manager-Investment at International Biotechnology Trust Plc

Relationship likelihood: Strong

Controller at Karolinska Development AB

Relationship likelihood: Strong

Co-Founder at Dilafor AB

Relationship likelihood: Strong

Head-Pre Clinical & Regulatory Director at Gesynta Pharma AB

Relationship likelihood: Strong

Chief Financial Officer at Athera Biotechnologies AB

Relationship likelihood: Strong

Chief Medical Officer at BioArctic AB

Relationship likelihood: Strong

Former Business Unit Manager Life Science at Industrifonden

Relationship likelihood: Strong

Associate Professor at Karolinska Institutet

Relationship likelihood: Strong

Paths to Ulf Richenberg
Potential Connections via
Relationship Science
You
Ulf Richenberg
Former Secretary & General Counsel at Karolinska Development AB
Career History
Secretary & General Counsel
2008 - 2020

Karolinska Development AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2006 and is headquartered in Solna, Sweden.

General Counsel
1995 - 2003
General Counsel
1992 - 1995

Scribona AB manufactures and distributes computers, operating systems, servers, and network products. The company's principal activities are the retail and distribution of computer products and high-tech office equipment such as PCs, handheld devices, printers, software and accessories.The company produces office products, office electronics information services in the Nordic countries. The company has five subsidiaries in Sweden, Luxemburg, UK, Finland and Norway. The company was founded in 1992 and is headquartered in Stockholm, Sweden

Boards & Committees
Director
Current
Member, Board of Directors
Prior

NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden.

Investments
Details Hidden

Karolinska Development AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2006 and is headquartered in Solna, Sweden.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ulf Richenberg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ulf Richenberg's profile does not indicate a business or promotional relationship of any kind between RelSci and Ulf Richenberg.